The ₹871-crore Initial Public Offer of dialysis services provider, Nephrocare Health Services, which operates with its brand NephroPlus, will open on December 10, with a price band of ₹ 438-460 per share.
The anchor-bidding of the Hyderabad-based company, which is valued at over ₹4,600 crore, will be on December 9 and the IPO subscription will close on December 12, according to an announcement.
The IPO consists of a fresh issue of shares aggregating to ₹353.4 crore and an Offer For Sale (OFS) of 1.12 crore shares valued at ₹517.6 crore at the upper end.
The minimum application lot is 32 shares, which will translate to a minimum investment of ₹14,720 for retail investors.
The promoters, Investcorp Private Equity Fund II, Healthcare Parent, Investcorp Growth Opportunity Fund, Edoras Investment Holdings Pte. Ltd, along with other shareholders, Investcorp India Private Equity Opportunity, International Finance Corporation and 360 One Special Opportunities Funds, will offload shares as a part of the OFS.